Carol H Wysham (Carol Wysham)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Community Dwelling

Medical Education

Glycemic Control

Top Venues

Diabetes, obesity & metabolism

Diabetes technology & therapeutics

Postgraduate medicine

JMIR medical education

This page only lists publications with an associated author ORCID identifier.

Publications

Richard M Bergenstal, Athena Philis-Tsimikas, Carol H Wysham, Molly C Carr, Juliana M Bue-Valleskey, Fady T Botros, Thomas Blevins, Julio Rosenstock
Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme. Diabetes, obesity & metabolism 26 (8) (2024)
Richard M Bergenstal, Athena Philis-Tsimikas, Carol H Wysham, Molly C Carr, Juliana M Bue-Valleskey, Fady T Botros, Thomas Blevins, Julio Rosenstock
Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme. Diabetes, obesity & metabolism (2024)
Gregg D Simonson, Amy B Criego, Tadej Battelino, Anders L Carlson, Pratik Choudhary, Sylvia Franc, Dana Gershenoff, George Grunberger, Irl B Hirsch, Diana Isaacs, Mary L Johnson, David Kerr, Davida F Kruger, Chantal Mathieu, Thomas W Martens, Revital Nimri, Sean M Oser, Anne L Peters, Tracey D Brown, Eugene E Wright, Carol H Wysham, Richard M Bergenstal
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens. Diabetes technology & therapeutics (2024)
Jennifer Okemah, Sola Quasheba Neunie, Alexander Daniel Noble, Carol H Wysham
Impact on Knowledge, Competence, and Performance of a Faculty-Led Web-Based Educational Activity for Type 2 Diabetes and Obesity: Questionnaire Study Among Health Care Professionals and Analysis of Anonymized Patient Records. JMIR formative research 7 (2023)
Katie Stringer Lucero, Amy Larkin, Stanislav O Zakharkin, Carol H Wysham, John E Anderson
The Impact of Web-Based Continuing Medical Education Using Patient Simulation on Real-World Treatment Selection in Type 2 Diabetes: Retrospective Case-Control Analysis. JMIR medical education 9 (2023)
Christophe E M De Block, Clifford J Bailey, Carol H Wysham, Andrea Hemmingway, Sheryl Elaine Allen, Jennifer Peleshok
Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective. Diabetes, obesity & metabolism (2022)
Carol H Wysham, Davida F Kruger
Practical Considerations for Initiating and Utilizing Flash Continuous Glucose Monitoring in Clinical Practice. Journal of the Endocrine Society 5 (9) (2021)
Carol H Wysham, Julio Rosenstock, Marion L Vetter, Hui Wang, Elise Hardy, Nayyar Iqbal
Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 study. BMJ open diabetes research & care 8 (1) (2021)
Athena Philis-Tsimikas, Wendy Lane, Ulrik Pedersen-Bjergaard, Carol H Wysham, Lars Bardtrum, Signe Harring, Simon R Heller
The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL. Diabetes, obesity & metabolism 22 (5) (2020)
David R Matthews, Carol H Wysham, Melanie Jane Davies, April Slee, Maria Alba, Mary Lee, Vlado Perkovic, Kenneth W Mahaffey, Bruce C Neal
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program. Diabetes, obesity & metabolism 22 (11) (2020)
Carol H Wysham, Jay H Shubrook
Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications. Postgraduate medicine 132 (8) (2020)
Simon R Heller, J Hans DeVries, Carol H Wysham, Charlotte T Hansen, Melissa V Hansen, Brian M Frier
Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2. Diabetes, obesity & metabolism 21 (7) (2019)
J Hans DeVries, Timothy S Bailey, Anuj Bhargava, Gregg Gerety, Janusz Gumprecht, Simon R Heller, Wendy Lane, Carol H Wysham, Bernard Zinman, Britta A Bak, Elise Hachmann-Nielsen, Athena Philis-Tsimikas
Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials. Diabetes, obesity & metabolism 21 (3) (2018)
Carol H Wysham, Riccardo C Bonadonna, Vanita R Aroda, Manuel Puig Domingo, Christoph Kapitza, William Stager, Christine Yu, Elisabeth Niemoeller, Elisabeth Souhami, Richard M Bergenstal, null null
Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. Diabetes, obesity & metabolism 19 (10) (2017)
Carol H Wysham, Julio Rosenstock, Marion L Vetter, Fang Dong, Peter Öhman, Nayyar Iqbal
Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes. Diabetes, obesity & metabolism 20 (1) (2017)